FOLD

Amicus Therapeutics, Inc. Press Releases

$7.69
*  
0.35
4.35%
Get FOLD Alerts
*Delayed - data as of Jan. 30, 2015  -  Find a broker to begin trading FOLD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    FOLD After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
National Tay Sachs and Allied Diseases Recruits Industry Leaders for Advisory Council
1/30/2015 10:27:00 AM - eTeligis


Amicus Therapeutics Announces Presentations and Posters at Lysosomal Disease Network WORLD Symposium
1/26/2015 7:30:00 AM - GlobeNewswire


Amicus Therapeutics Provides Full-Year 2015 Strategic Outlook and Financial Guidance
1/12/2015 7:30:00 AM - GlobeNewswire


Amicus Therapeutics Announces Positive Phase 3 Data on Cardiac Endpoints From Fabry Monotherapy Study 011 and Long Term Extension Study
1/8/2015 7:30:00 AM - GlobeNewswire


Amicus Therapeutics to Present Program Updates at 33rd Annual J.P. Morgan Healthcare Conference
12/22/2014 7:30:00 AM - GlobeNewswire


Amicus Therapeutics Added to NASDAQ Biotechnology Index (NBI)
12/22/2014 7:30:00 AM - GlobeNewswire


Amicus Therapeutics to Submit European Marketing Application for Migalastat Monotherapy for Fabry Disease
12/11/2014 7:30:00 AM - GlobeNewswire


Amicus Therapeutics to Present at Oppenheimer Healthcare Conference
12/4/2014 4:00:00 PM - GlobeNewswire


Amicus Therapeutics Announces Closing of Underwritten Offering of Common Stock and Full Exercise of Over-Allotment Option
11/24/2014 4:00:00 PM - GlobeNewswire


Amicus Therapeutics Prices Underwritten Offering of Common Stock
11/18/2014 7:15:00 PM - GlobeNewswire


Amicus Therapeutics Announces Public Offering of Common Stock
11/17/2014 4:00:00 PM - GlobeNewswire


Amicus Therapeutics Announces Positive Phase 3 Data on Cardiac and Composite Endpoints from Fabry Monotherapy Study 012 at American Society of Nephrology
11/15/2014 10:00:00 AM - GlobeNewswire


Amicus Therapeutics Announces Positive Phase 3 Data on Cardiac and Composite Endpoints from Fabry Monotherapy Study 012 at American Society of Nephrology
11/15/2014 10:00:00 AM - GlobeNewswire


Amicus Therapeutics Announces Third Quarter 2014 Financial Results and Corporate Updates
11/6/2014 4:00:00 PM - GlobeNewswire


Amicus Therapeutics Announces Timing of Third Quarter 2014 Financial Results, Upcoming Scientific Conference and Other Corporate Updates
11/3/2014 8:00:00 AM - GlobeNewswire